Intravenous immunoglobulin therapy for the antiphospholipid syndrome;Intérêt des immunoglobulines intraveineuses au cours du syndrome des antiphospholipides

Revue de Medecine Interne

Volumn 20, Issue SUPPL. 4, 1999, Pages 410-413

  Bletry O ^a   Blanc, A S ^a   Piette, A M ^a  

^a FOCH HOSPITAL   (France)

Author keywords

Antiphospholipid antibodies antiphospholipid syndrome; Intravenous immunoglobulins; Recurrent pregnancy loss

Indexed keywords

ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; IMMUNOGLOBULIN; VITAMIN K GROUP;

ANTIPHOSPHOLIPID SYNDROME; DRUG ANTAGONISM; HUMAN; IMMUNOLOGY; PATIENT SELECTION; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; REVIEW; THROMBOCYTOPENIA; THROMBOSIS; TREATMENT OUTCOME;

ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; FIBRINOLYTIC AGENTS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; PATIENT SELECTION; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; THROMBOCYTOPENIA; THROMBOSIS; TREATMENT OUTCOME; VITAMIN K;

EID: 0342710760     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Harris EN, Ghavari AE, Boey ML. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; ii : 1211-4.
2. Harris EN, Bagueley E, Asherson RA, Hughes GRV. Clinical and serological features of the antiphospholipid syndrome. Br J Rheum 1987; 26 : 19.
3. Harris EN. A reassessment of the antiphospholipid syndrome. J Rheumatol 1990; 17 : 733-5.
4. e Congrès de la SNFMI; décembre 1991; Angers.
5. Derksen RHWM, de Groot PG, Kater L, Nieuwenhuis HK. Patients with antiphospholipid antibodies and veinous thrombosis should receive long term anticoagulant treatment. Ann Rheum Bi 1993; 52 : 689-92.
6. Rosove MH, Brewer PMC. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 1992; 117 : 303-8.
7. Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GRV. The management of thrombosis in the antiphospholipid syndrome. New Engl J Med 1995; 332 : 993-7.
8. Frances C, Blétry O, Piette JC. Dermatologic manifestations in the antiphospholipid syndrome. In: Antiphospholipid syndrome. Asherson RA, Cervera R, Piette JC, Shoenfeld Y, eds. New York: CRC Press; 1996. p. 201-11.
9. Asherson RA, Cervera R, Piette JC, Font J, Lie JT, Burcoglu A, et al. Catastrophic antiphospholipid syndrome: clinical and laboratory features of 50 patients. Medicine 1998; 77 : 195-207.
10. Vandenberghe P, Zachee P, Verstraete S, Demuynck H, Boogaerts MA, Verhoef GEG. Successful control of refractory and life-threatening autoimmune hemolytic anemia with intravenous immunoglobulins in a man with the primary antiphospholipid syndrome. Ann Hematol 1996; 73 : 253-6.
11. Cervera R, Asherson RA, Font J, Tikly M, Pallarés L, Chamorro A, et al. Chorea in the antiphospholipid syndrome: clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature. Medicine 1997; 76 : 203-12.
12. Nilsson IM, Astedt B, Hedner U, Berezin D. Intra uterine death and circulating anticoagulant ("antithromboplastin"). Acta Med Scand 1975; 197 : 153-9.
13. Soulier JP, Boffa MC. Avortements à répétition, thrombpses et anticoagulant circulant antithromboplastine. Trois observations. Presse Méd 1980; 9 : 859-65.
14. Lubbe WF, Butler WS, Palmer SJ, Liggins GC. Fetal survival after prednisone suppression of maternal lupus anticoagulant. Lancet 1983; ii : 1361-3.
15. Blétry O, Piette AM. Recurrent fetal loss and antiphospholipid antibodies: clinical and therapeutic aspects. Inf Dis Obstet Gynecol 1997; 5 : 183-91.
16. Kutteh WH. Antiphospholipid antibody - associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996; 174 : 1584-9.
17. Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997; 314 : 253-7.
18. François A, Freund M, Daffos F, Remy P, Aïach M, Jacquot C. Repeated fetal losses and the lupus anticoagulant. Ann Intern Med 1988; 109 : 993-4.
19. Carreras LO, Perez GN, Vega HR, Casavilla F. Lupus anticoagulant and recurrent fetal loss: successful treatment with gammaglobulin. Lancet 1988; 2 : 393-4.
20. Scott JR, Branch DW, Kochenour NK, Ward K. Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy loss caused by antiphospholipid antibodies an Rh immunization. Am J Obstet Gynecol 1989; 159 : 1055-6.
21. Parke A, Maier D, Wilson D, Andreoli J, Ballow M. Intravenous gammaglobulin, antiphospholipid antibodies, and pregnancy. Ann Intern Med 1989; 110 : 495-6.
22. Wapner RJ, Cowchock FS, Shapiro SS. Successful treatment in two women with antiphospholipid antibodies and refractory pregnancy losses with intravenous immunoglobulin infusions. Am J Obstet Gynecol 1989; 161 : 1271-2.
23. Spinnato JA, Clark AL, Pierangeli SS, Harris EN. Intravenous immunoglobulin therapy for the antiphospholipid syndrome in pregnancy. Am J Obstet Gynecol 1995; 172 : 690-4.
24. Kwak JYH, Quilty EA, Gilman-Sachs A, Beaman KD, Beer AE. Intravenous immunoglobulin infusion therapy in women with recurrent spontaneous abortions of immune etiologies. J Reprod Immunol 1995; 28 : 175-88.
25. Marzusch K, Dietl J, Klein R, Hornung D, Neuer A, Berg PA. Recurrent first trimester spontaneous abortion associated with antiphospholipid antibodies: a pilot study of treatment with intravenous immunoglobulin. Acta Obstet Gynecol Scand 1996; 75 : 922-6.
26. Cosserat J, Blétry O, Laraki R, Horellou MH, Weill B, Godeau P. Traitement du syndrome de Soulier-Boffa par les immunoglobulines intraveineuses. Dissociation possible entre effets cliniques et biologiques. Rev Méd Interne 1993; 14 : 406.
27. Sher G, Zouves C, Feinman M, Maassarani G, Matzner W, Chong P, et al. A rational basis for the use of combined heparin-aspirin and IVIG immunotherapy in the treatment of recurrent IVF failure associated with antiphospholipid antibodies. AJRI 1998; 39 : 391-4.
28. Valensise H, Vaquero E, De Carolis C, Stipa E, Perricone R, Arduini D, et al. Normal fetal growth in women with antiphospholipid syndrome treated with high-dose intravenous immunoglobulin (IVIG). Prenatal Diagn 1995; 15 : 509-17.